However, Lhomond et al. recently reported that IRE1α-XBP1 downstream signals play antagonistic roles in cancer progression, whereby XBP1s provides protumoral signals, whereas RNA regulated IRE1-dependent decay (RIDD) of mRNA and miR-17 elicits antitumoral effects [37]. The gene discussed is XBP1; the disease is cancer.